Kinnate Biopharma Funding: $195M Raised, Series C (2020)
Kinnate Biopharma is based in San Diego. It has raised $195M in total funding. Latest round: Series C.
Kinnate Biopharma funding overview
Kinnate Biopharma is based in San Diego. Kinnate Biopharma has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for Kinnate Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Domain Associates, Foresite Capital, HBM Partners, OrbiMed, SR ONE, The Column Group and 11 others. 17 distinct backers are named across the disclosed rounds.
Kinnate Biopharma at a glance
Total raised
$195M
Latest round
Series C
Latest round date
August 2020
Headquarters
San Diego
Notable investors
Domain Associates, Foresite Capital, HBM Partners, OrbiMed, SR ONE, The Column Group, Vivo Capital, Boxer Capital
Frequently asked about Kinnate Biopharma funding
How much has Kinnate Biopharma raised?
Kinnate Biopharma has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Kinnate Biopharma?
Domain Associates, Foresite Capital, HBM Partners, OrbiMed, SR ONE, The Column Group are named among the investors backing Kinnate Biopharma.
What was the latest Kinnate Biopharma funding round?
The most recent disclosed round is a Series C, announced in August 2020.
Where is Kinnate Biopharma based?
Kinnate Biopharma is based in San Diego.
When did Kinnate Biopharma last raise?
The last disclosed Kinnate Biopharma round closed in August 2020 at Series C.
Kinnate Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
